Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.

about

Efficacy and Safety of Ranolazine in Diabetic Patients: A Systematic Review and Meta-analysis.

P2860

Q49909252-78D6524E-93A4-4A4C-9B3D-46E08DC1F8D5

P2860

Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.

Item

http://www.wikidata.org/entity/Q51019687

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@en

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@nl

type

Item

label

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@en

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@nl

prefLabel

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@en

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@nl

P1476

Ranolazine After Incomplete Pe ...... tes Mellitus: RIVER-PCI Trial.

@en

P2093

Alexander C Fanaroff

http://www.w3.org/2001/XMLSchema#string

Giora Weisz

http://www.w3.org/2001/XMLSchema#string

Gregg W Stone

http://www.w3.org/2001/XMLSchema#string

Karen P Alexander

http://www.w3.org/2001/XMLSchema#string

Kristi Prather

http://www.w3.org/2001/XMLSchema#string

Stefan K James

http://www.w3.org/2001/XMLSchema#string

P2860

Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina.

Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.

Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.

Increased persistent sodium current due to decreased PI3K signaling contributes to QT prolongation in the diabetic heart

P304

2304-2313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2017.02.056

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28473136

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

P932

5784418

http://www.w3.org/2001/XMLSchema#string

Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.

about

P2860

P2860

Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932